RadNet, Inc. (RDNT)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-05
$78.01-2.80%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-05
QuarterlyIQ Insights · RDNT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 367.8% |
| Our one-year growth estimate | diamond | 21.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 346.7 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 19 industry peers
RDNT — capital allocation — The Closing Shares and any
Dated 2026-10-26
The Closing Shares and any Earn-Out Shares to be issued as consideration under the Merger Agreement will be issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act ”), and/or Rule 506 of Regulation D promulgated thereunder.
Why it matters: RadNet raised its 2026 imaging center revenue range to $2,370 million to $2,420 million. Q3 results test whether growth stays on that path.
Supportive ifOn November 9, RadNet keeps or raises its 2026 imaging center revenue range of $2,370 million to $2,420 million.
Worry ifRadNet cuts its 2026 imaging center revenue range below $2,370 million.
Why it matters: The deal adds hospital radiology work and a new business segment. A timely close would start the path to the stated first-year revenue and earnings contribution.
Supportive ifRadNet reports the ONRAD deal closed. The stated first-year revenue range of $190 million to $200 million has no material change.
Worry ifRadNet or ONRAD reports the deal ended, faced a delay past early 2027, or hit a key approval block.
Why it matters: RadNet said it plans to use the cleared tool across its breast imaging centers by year-end. A broad rollout can add sales and lower costs.
Supportive ifBy year-end, RadNet confirms the breast ultrasound AI tool is in use across its breast imaging centers.
Worry ifRadNet reports that the tool was not rolled out across its breast imaging centers by year-end.
Why it matters: The deal includes up to $210 million in earnout value tied to 2027 EBITDA targets. The reported result will test whether ONRAD reaches those targets.
Watch forRadNet reports ONRAD met its 2027 EBITDA target and earned some or all of the earnout.
Also watch forRadNet reports ONRAD missed its 2027 EBITDA target and no earnout is due.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$163 on $10,000 · ±1.6% | How much price usually moves either way. |
| Bad day | $434 loss on $10,000 · 4.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,860 loss on $10,000 · 38.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.